Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Avery Thomson"'
Autor:
Svitlana Garbuzova-Davis, Crupa Kurien, Avery Thomson, Dimitri Falco, Sohaib Ahmad, Joseph Staffetti, George Steiner, Sophia Abraham, Greeshma James, Ajay Mahendrasah, Paul R. Sanberg, Cesario V. Borlongan
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-22 (2017)
Abstract Vascular pathology, including blood-CNS barrier (B-CNS-B) damage via endothelial cell (EC) degeneration, is a recently recognized hallmark of Amyotrophic Lateral Sclerosis (ALS) pathogenesis. B-CNS-B repair may be a new therapeutic approach
Externí odkaz:
https://doaj.org/article/85004381706b4af799c72eac9a5df5c6
Publikováno v:
Wounds : a compendium of clinical research and practice.
According to the International Diabetes Federation, approximately 463 million adults live with diabetes mellitus (DM), a number projected to increase to 700 million by 2045; a diabetic foot ulcer (DFU) will occur in about 15% of that population. Mult
Autor:
Crupa Kurien, Daniel Hennessey, Josean Cruz, Sandra Zivkovic, Jennifer Barretta, Jared Ehrhart, Jaheem Joseph, Vedad Delic, Alison E. Willing, Svitlana Garbuzova-Davis, Patrick C. Bradshaw, Avery Thomson
Publikováno v:
Journal of Neuroscience Research. 96:1353-1366
Amyotrophic lateral sclerosis (ALS) is an adult onset neurodegenerative disease characterized by progressive motor neuron degeneration in the brain and spinal cord leading to muscle atrophy, paralysis, and death. Mitochondrial dysfunction is a major
Autor:
Ajay Mahendrasah, George Steiner, Avery Thomson, Svitlana Garbuzova-Davis, David J. Eve, Paul R. Sanberg, Cesar V. Borlongan, Crupa Kurien
Publikováno v:
Oncotarget
Blood-spinal cord barrier (BSCB) alterations, including capillary rupture, have been demonstrated in animal models of amyotrophic lateral sclerosis (ALS) and ALS patients. To date, treatment to restore BSCB in ALS is underexplored. Here, we evaluated
Autor:
Avery Thomson, Hua Qin, Naoki Tajiri, Harry R. van Loveren, Paul R. Sanberg, Jennifer Barretta, Cesario V. Borlongan, Jerry V. Abraham, Edward M Haller, Svitlana Garbuzova-Davis, Eithan D. Haim, Stephanie N. Williams, Aric Frisina-Deyo
Publikováno v:
Journal of Neuropathology & Experimental Neurology. 75:673-688
We previously demonstrated blood-brain barrier impairment in remote contralateral brain areas in rats at 7 and 30 days after transient middle cerebral artery occlusion (tMCAO), indicating ischemic diaschisis. Here, we focused on effects of subacute a
Autor:
Sophia Abraham, Cesario V. Borlongan, Ajay Mahendrasah, Crupa Kurien, Avery Thomson, George Steiner, Greeshma James, Sohaib Ahmad, Svitlana Garbuzova-Davis, Paul R. Sanberg, Joseph F. Staffetti, Dimitri Falco
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-22 (2017)
Scientific Reports
Scientific Reports
Vascular pathology, including blood-CNS barrier (B-CNS-B) damage via endothelial cell (EC) degeneration, is a recently recognized hallmark of Amyotrophic Lateral Sclerosis (ALS) pathogenesis. B-CNS-B repair may be a new therapeutic approach for ALS.